Literature DB >> 432438

Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.

D W Schneck, J F Pritchard, A H Hayes.   

Abstract

An HPLC method for the quantitative determination of propranolol, 4-hydroxypropranolol, and propranolol glycol in human plasma is described. The limits of sensitivity for the method were: 1 ng/ml propranolol; 5 ng/ml 4-hydroxypropranolol; and 1 ng/ml propranolol glycol. Data obtained from 6 healthy volunteers given a single 160 mg oral dose of propranolol revealed mean (+/- SEM) peak plasma levels of 31 +/- 10 ng/ml for 4-hydroxypropranolol and 9 +/- 2 ng/ml for propranolol glycol. These plasma levels were less than the peak concentrations recorded for propranolol (123 +/- 34 ng/ml. The rates of plasma decay of these two metabolites were greater than that observed for propranolol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 432438

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  2 in total

1.  Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.

Authors:  D M Hibbard; J R Peters; D B Hunninghake
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 2.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.